What does it mean if Parathyroid Hormone (PTH) is mid to high normal, calcium levels are elevated (hypercalcemia), and Vitamin D, specifically 25-hydroxyvitamin D (25-OH-D), is very high?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Elevated calcium levels in conjunction with mid to high normal parathyroid hormone (PTH) levels and very high 25-hydroxyvitamin D levels may indicate vitamin D toxicity or hypervitaminosis D, potentially caused by excessive supplementation 1. This condition can lead to hypercalcemia, which may require discontinuation of vitamin D supplements.

  • The desirable serum 25-hydroxyvitamin D (25-OH-D) levels are not well established, but levels above 75 nmol L−1 may be considered excessive 1.
  • Primary hyperparathyroidism should be ruled out, especially if PTH levels are elevated and serum calcium levels are high 1.
  • Treatment may involve discontinuation of vitamin D supplements and potentially treatment with glucocorticoids, such as prednisone, to reduce calcium levels.
  • Monitoring of PTH, calcium, and 25-hydroxyvitamin D levels every 3-6 months is recommended to assess the effectiveness of treatment and prevent long-term complications.
  • It is essential to note that all individuals are at risk of developing vitamin D deficiency, especially after bariatric surgery, but those with more malabsorptive procedures are at greater risk 1.

From the Research

Interpretation of Laboratory Results

  • Mid to high normal Parathyroid Hormone (PTH) levels, elevated calcium levels (hypercalcemia), and very high 25-hydroxyvitamin D (25-OH-D) levels can be indicative of several conditions, including primary hyperparathyroidism (PHPT) 2, 3, 4.
  • Hypercalcemia is defined as a serum calcium concentration >10.5 mg/dL and can be caused by various factors, including excessive PTH production, production of parathyroid hormone-related protein (PTHrp), bone metastasis, extrarenal activation of vitamin D, and ectopic PTH secretion 5.
  • Very high 25-OH-D levels can contribute to hypercalcemia, as 25-OH-D can bind to the vitamin D receptor and increase calcium absorption in the gut 6.

Possible Causes

  • Primary hyperparathyroidism (PHPT) is a condition characterized by the autonomous production of PTH, leading to hypercalcemia or normal-high serum calcium levels, and elevated or inappropriately normal serum PTH concentrations 2, 3, 4.
  • Vitamin D-mediated hypercalcemia can occur due to excessive ingestion of vitamin D, ectopic production of 1,25-dihydroxyvitamin D, or impaired degradation of 1,25-dihydroxyvitamin D 6.
  • Other possible causes of hypercalcemia include malignancies, granulomatous diseases, and familial hypocalciuric hypercalcemia (FHH) 5, 6, 3.

Diagnostic Considerations

  • The diagnosis of PHPT is biochemical and requires the measurement of PTH, calcium, phosphate, and 25-OH-D levels 2, 4.
  • A definitive diagnosis of PHPT can only be made by demonstrating persistent hypercalcemia or normal-high serum calcium levels in the presence of inappropriately normal or elevated serum PTH concentrations 2.
  • The differential diagnosis of PHPT includes other causes of hypercalcemia, such as tumoral hypercalcemia, granulomatous disease, and vitamin D or A intoxication 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Diagnostic evaluation and differential diagnosis of primary hyperparathyroidism].

Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009

Research

Calcium, parathyroid hormone, and vitamin D in patients with primary hyperparathyroidism: normograms developed from 10,000 cases.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2011

Research

A Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hypercalcemia.

Medical science monitor : international medical journal of experimental and clinical research, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.